New study investigates hidden heart risks of cancer immunotherapy
NCT ID NCT06020651
First seen Apr 14, 2026 · Last updated May 17, 2026 · Updated 6 times
Summary
This study looked at how immune checkpoint inhibitors, a type of cancer drug, might cause artery disease in 39 people with cancer. Researchers used ultrasound and blood tests to find early signs of blood vessel damage. The goal was to better understand these side effects, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
INstitut Mutualiste Montsouris
Paris, France
Conditions
Explore the condition pages connected to this study.